§ 01 / The sequence
Fundraising steps, end to end.
Each phase has its own narrative, instruments, and signals. Move through them deliberately — investors at each stage are reading for different things.
PHASE 01
Pre-Seed & Conviction
$250K — $1M
Validate the fundamental thesis. Focus on technical prototyping, core team formation, and the earliest signs of demand.
- 01Incorporate (Delaware C-Corp or local equivalent)
- 02Assign IP & sign founder agreements
- 03Build MVP and recruit 10 design partners
- 04Draft a 1-page narrative & deck (10–12 slides)
- 05Open a SAFE round with a clear post-money cap
Parameters
- Typical dilution
- 10–15%
- Instrument
- SAFE / Convertible
- Runway target
- 12–18 months
PHASE 02
Seed
$1M — $5M
Demonstrate initial market resonance. Professionalize the cap table, hire the founding team, and prove a repeatable wedge.
- 01Reach $10–30K MRR or strong qualitative traction
- 02Hire 3–6 key engineers / GTM leads
- 03Build a data room (metrics, cohorts, cap table)
- 04Run a 4–6 week structured process with a lead
- 05Negotiate priced round: pref shares, board seat
Parameters
- Typical dilution
- 15–20%
- Instrument
- Priced equity
- Runway target
- 18–24 months
PHASE 03
Series A
$8M — $20M
Scale the unit economic model, formalize board governance, and turn early traction into a repeatable revenue engine.
- 01Reach $1–2M ARR with healthy retention
- 02Demonstrate CAC payback < 18 months
- 03Codify GTM motion and sales playbook
- 04Recruit independent board member
- 05Negotiate pro-rata, info rights, protective provisions
Parameters
- Typical dilution
- 18–25%
- Instrument
- Series A Preferred
- Runway target
- 24 months
PHASE 04
Series B & Beyond
$25M — $100M+
Compound the growth machine. Expand into new markets, harden operations, and prepare for late-stage capital or exit.
- 01Reach $5–15M ARR with > 100% NRR
- 02Build finance, legal, and people functions
- 03Open new geographies or product lines
- 04Engage growth/crossover funds
- 05Model secondary liquidity for founders & early team
Parameters
- Typical dilution
- 15–20%
- Instrument
- Series B+ Preferred
- Runway target
- 24–36 months